Company intelligence
NewBiologix
Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders.
Biotechnology Research
Epalinges, CH
25 employees
Founded 2023
3 public signals
About NewBiologix
Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies.
Verified activity
Signals from NewBiologix
3 published signals
Presence & Recognition
NewBiologix is attending the Advanced Therapies Europe 2026 conference in Barcelona.
Reported by NewBiologix
Partnerships
NewBiologix and Synastra Biotechnology formed a partnership to advance stable rAAV manufacturing for Duchenne muscular dystrophy gene therapy.
Reported by NewBiologix
Partnerships
NewBiologix and Synastra will combine genomic engineering, AAV vector design, rare-disease gene therapy, and translational development with proprietary cell engineering and rAAV manufacturing technologies to develop a stable producer cell line for Synastra’s Duchenne muscular dystrophy gene therapy program.
Reported by NewBiologix